Pharmacoepidemiology is an international, peer-reviewed, open access journal on high-quality epidemiological, clinical research across the fields of clinical pharmacology and epidemiology, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 34.2 days after submission; acceptance to publication is undertaken in 4.9 days (median values for papers published in this journal in the second half of 2023).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • Pharmacoepidemiology is a companion journal of Pharmaceuticals.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Cancers, Healthcare, Pharmaceuticals, Pharmaceutics, Pharmacoepidemiology
Advance in Cancer Pharmacoepidemiology Topic Editors: Shih-Chieh Shao, Edward Chia-Cheng Lai
Deadline: 20 February 2025
Special Issue in Pharmacoepidemiology
Anti-Infectives: Pharmacoepidemiology and Clinical Pharmacology Guest Editors: Lee Nguyen, Jason Yamaki
Deadline: 31 July 2024
Special Issue in Pharmacoepidemiology
Recent Advances in the Pharmacoepidemiology of Antirheumatic Medication Guest Editors: Roberta Foti, Beatrice Maranini, Veronica Venturelli
Deadline: 31 December 2024
Back to TopTop